Modern Strategies for Managing Deviations and Corrective and Preventive Actions in the Pharmaceutical Quality System

Citation: Prasantha Pujari, "Modern Strategies for Managing Deviations and Corrective and Preventive Actions in the Pharmaceutical Quality System", Universal Library of Engineering Technology, Volume 03, Issue 01.

Copyright: This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The article examines the transformation of deviation management and corrective and preventive actions (CAPA) in the pharmaceutical quality system as a key decision-making mechanism. The relevance of the work is determined by a shift in regulatory and manufacturing focus from the formal closure of records to demonstrable reductions in patient risk, strengthened data integrity, and enhanced quality maturity in the context of increasingly complex technologies and supply chains. The aim of the study is to analytically synthesize the latest empirical and methodological sources to construct a risk-based, data-driven model for managing deviations and CAPAs. The novelty of the approach lies in integrating metrics of quality system performance, the structure of inspectional non-conformities by criticality, and data integrity strategies into a single conceptual framework that interprets deviations as controllable signals rather than administrative exceptions. Based on narrative evidence synthesis, a model of the deviation and CAPA life cycle is proposed, in which the contours of immediate risk containment, evidence-based investigation grounded in testable hypotheses, and systematically designed corrective and preventive actions, with subsequent evaluation of their effectiveness against predefined metrics, are clearly differentiated. It is demonstrated that the transition from a reactive logic to a predictive one relies on cross-functional interaction, discipline in primary actions, the embedding of changes into change control, qualification, and validation procedures, as well as on digital connectivity of records in electronic quality systems, which enables trending of weak signals and prevention of regulatorily significant non-conformities. The article will be of interest to quality assurance professionals, managers of pharmaceutical manufacturing sites, validation experts, and developers of electronic quality management systems.

Keywords: Pharmaceutical Quality System, Deviations, Corrective and Preventive Actions, CAPA.

https://doi.org/10.70315/uloap.ulete.2026.0301014